ARIX BIOSCIENCE PLC
ARIX | IL
Overview
Corporate Details
- ISIN(s):
- GB00BD045071
- LEI:
- 213800OVT3AHQCXNIX43
- Country:
- United Kingdom
- Address:
- 1 More London Place, SE1 2AF London
- Website:
- https://arixbioscience.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
ARIX BIOSCIENCE PLC invests in innovative life sciences companies, supporting breakthroughs in biotechnology and healthcare.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2024-02-12 14:02 |
Declaration of Voting Results & Voting Rights Announcements
Arix Bioscience Plc - Results of 2nd General Meeting
|
English | 123.9 KB | |
| 2024-02-12 13:00 |
Declaration of Voting Results & Voting Rights Announcements
Scheme Effective
|
English | 28.0 KB | |
| 2024-02-12 08:00 |
Regulatory News Service
Suspension of Trading in Shares
|
English | 19.2 KB | |
| 2024-02-07 12:30 |
Capital/Financing Update
Transaction Update
|
English | 30.8 KB | |
| 2024-01-29 14:06 |
Declaration of Voting Results & Voting Rights Announcements
Arix Bioscience Plc - Results of 1st General Meeting
|
English | 61.5 KB | |
| 2024-01-29 13:15 |
Declaration of Voting Results & Voting Rights Announcements
Results of First General Meeting
|
English | 28.6 KB | |
| 2024-01-24 18:30 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 66.9 KB | |
| 2024-01-23 11:42 |
General Meeting Notice
Arix Bioscience Plc - Circular and Notice of Second General Meeting
|
English | 138.5 KB | |
| 2024-01-23 08:00 |
General Meeting Notice
Update on the Scheme and Publication of Notice of Second General Meeting
|
English | 39.2 KB | |
| 2024-01-22 08:00 |
Board/Management Change
Update on the Scheme and Resignation of Directors
|
English | 22.4 KB | |
| 2024-01-19 08:01 |
Regulatory News Service
Financial update on Harpoon Therapeutics acquisition by Merck (MSD)
|
English | 11.7 KB | |
| 2024-01-19 08:00 |
Regulatory News Service
Unaudited NAV for December 2023
|
English | 15.1 KB | |
| 2024-01-08 18:15 |
Regulatory News Service
Portfolio company Harpoon Therapeutics to be acquired by Merck (MSD)
|
English | 58.4 KB | |
| 2024-01-05 08:00 |
Prospectus
Publication of Circular and RTW Bio Prospectus
|
English | 43.5 KB | |
| 2024-01-04 18:30 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 66.4 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
PREDILIFE | France | ALPRE | |
|
PROSPEX ENERGY PLC | United Kingdom | PXEN | |
|
Prostatype Genomics AB | Sweden | PROGEN | |
|
Psych Capital Plc | United Kingdom | PSY | |
|
Pure Biologics S.A. | Poland | PUR | |
|
Puretech Health PLC | United States of America | PRTC | |
|
Purple Biotech Ltd. | Israel | PPBT | |
|
QLife Holding AB | Sweden | QLIFE | |
|
Quantum Genomics | France | ALQGC | |
|
QUIA PHARMA AB | Sweden | QUIA |